The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease

The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease; A Single Center, Prospective Observational Study

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02981134

Acronym

CT BVS

Enrollment

Registered

2016-12-05

Start date

2021-12-31

Completion date

2023-12-31

Last updated

2021-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Disease

Keywords

bioabsorbable scaffold, computed tomography

Brief summary

The purpose of this study is to evaluate usefulness of coronary computed tomographic scan for prediction of clinical events after everolimus-eluting bioabsorbable scaffold implantation for coronary artery disease.

Interventions

PROCEDUREComputed tomographic scan

after 1year of BVS implantation, computed tomographic scan will be performed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients treated withBioresobable Vascular Scaffold for coronary disease

Exclusion criteria

* History of allergy to contrast * Serum Creatinine \> 2.0 mg/dl * Severe arrhythmia * Pregnancy or breast feeding

Design outcomes

Primary

Measure	Time frame	Description
Computed tomographic scan parameters	3 years	Computed tomographic scan parameters predicting clinical outcomes

Secondary

Measure	Time frame	Description
Thrombosis	1 year	Thrombosis on computed tomographic scan
Lumen loss	1 year	lumen loss: the change in minimal lumen diameter on computed tomographic scan
Restenosis	1 year	Restenosis on computed tomographic scan
Clinical outcomes	3 years	Death, target vessel myocardial infarction, clinically driven revascularization
Proportion of analyzable lesion	3 years	small vessel defined diameter less than 3.0 mm, bifurcation, overlapped lesion
Positive predictive value	3 years	Positive predictive value on computed tomographic scan

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026